Show simple item record

dc.contributor.authorSmith, Tim A D
dc.date.accessioned2010-10-19T12:08:38Z
dc.date.available2010-10-19T12:08:38Z
dc.date.issued2010-01
dc.identifier.citationSmith , T A D 2010 , ' Influence of chemoresistance and p53 status on fluoro-2-deoxy-D-glucose incorporation in cancer ' , Nuclear Medicine and Biology , vol. 37 , no. 1 , pp. 51-55 . https://doi.org/10.1016/j.nucmedbio.2009.08.007en
dc.identifier.issn0969-8051
dc.identifier.otherPURE: 2893490
dc.identifier.otherPURE UUID: cf2b76fe-e770-417f-bff7-86fbc2ad6dab
dc.identifier.otherScopus: 72449143571
dc.identifier.urihttp://hdl.handle.net/2164/774
dc.format.extent5en
dc.language.isoeng
dc.relation.ispartofNuclear Medicine and Biologyen
dc.rightsSmith, TAD 2010, 'Influence of chemoresistance and p53 status on fluoro-2-deoxy-D-glucose incorporation in cancer' Nuclear Medicine and Biology, vol 37, no. 1, pp. 51-55. doi: 10.1016/j.nucmedbio.2009.08.007en
dc.subjectradionuclide studyen
dc.subjecttreatmenten
dc.subjectcanceren
dc.subject2-deoxy-2-fluoroglucoseen
dc.subjectchemotherapyen
dc.subjectantineoplastic agenten
dc.subjectmutationen
dc.subjectp53 proteinen
dc.subjectprognosisen
dc.subjectpredictive factoren
dc.subjecthumanen
dc.subjectincorporationen
dc.subjecttreatment resistanceen
dc.subjectpositron emission tomographyen
dc.subjectemission tomographyen
dc.subjectmalignant tumoren
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleInfluence of chemoresistance and p53 status on fluoro-2-deoxy-D-glucose incorporation in canceren
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen, Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen, Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen, Institute of Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPostprinten
dc.identifier.doihttps://doi.org/10.1016/j.nucmedbio.2009.08.007


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record